Squamous cell papilloma of the conjunctiva due to human papillomavirus (HPV): Presentation of two cases and review of literature

Clinical Ophthalmology

Volumn 6, Issue 1, 2012, Pages 1553-1561

  Kalogeropoulos, Chris ^a   Koumpoulis, Ioannis ^a   Papadiotis, Evangelos ^a   Zioga, Aikaterini ^a   Gkrepi, Konstantina ^a   Pappa, Chrisavgi ^a   Paschides, Constantinos ^a   Malamou Mitsi, Vasiliki ^a   Aspiotis, Miltiadis ^a  

^a UNIVERSITY OF IOANNINA   (Greece)

Author keywords

Conjunctiva; Human papillomavirus; In situ hybridization; Koilocytosis; Papilloma; Polymerase chain reaction

Indexed keywords

MITOMYCIN C; PROTEIN VP16; VIRUS DNA; VIRUS PROTEIN;

ACANTHOSIS; ADULT; AMNION; CANCER RECURRENCE; CANCER SURGERY; CASE REPORT; CELLULAR PARAMETERS; CLINICAL FEATURE; CONJUNCTIVA TUMOR; CONJUNCTIVAL SQUAMOUS CELL PAPILLOMA; CORNEA; CRYOTHERAPY; DISEASE DURATION; DNA DEGRADATION; DNA HYBRIDIZATION; EYE REDNESS; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 6; IMMUNOHISTOCHEMISTRY; KOILOCYTOSIS; MALE; PAPILLOMA; PAPILLOMATOSIS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; REVIEW; TUMOR GROWTH; VISUAL ACUITY; VISUAL IMPAIRMENT; WART VIRUS;

EID: 84866654976     PISSN: 11775467     EISSN: 11775483     Source Type: Journal    
DOI: 10.2147/OPTH.S34999     Document Type: Review

References (42)

1. Weinstock H, Berman S, Cates W Jr. Sexually transmitted diseases among American youth: incidence and prevalence estimates, 2000. Perspect Sex Reprod Health. 2004;36(1):6-10.
2. Garland SM, Steben M, Sings HL, et al. Natural history of genital warts: analysis of the placebo arm of 2 randomized phase III trials of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine. J Infect Dis. 2009;199(6):805-814.
3. Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
4. Bosch FX, de Sanjosé S. Chapter1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;31:3-13.
5. Clifford GM, Smith JS, Plummer M, et al. Human papillomavirus types in invasive cervical cancer worldwide: a meta-analysis. Br J Cancer. 2003;88(1):63-73.
6. Hsu SM, Raine L, Fanger H. Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem. 1981;29(4):577-580.
7. Nakamura Y, Mashima Y, Kameyama K. Human papilloma virus DNA detected in case of inverted squamous papilloma of the lacrimal sac. Br J Ophthalmol. 1995;79(4):392-393
8. Coates PJ, d'Ardenne AJ, Khan G, Kangro HO, Slavin G. Simplified procedures for applying the polymerase chain reaction to routinely fixed paraffin wax sections. J Clin Pathol. 1991;44(2):115-118.
9. Legrand B, Mazancourt P, Durigon, Khalifat V, Crainic K. DNA genotyping of unbuffered formalin fixed paraffin embedded tissues. Forensic Sci Int. 2002;125(2-3):205-211.
10. Sjö NC, Heegaard S, Prause JU, von Buchwald C, Lindeberg H. Human papillomavirus in conjunctival papilloma. Br J Ophthalmol. 2001;85(7):785-787.
11. Nakamura Y, Mashima Y, Kameyama K, Mukai M, Oguchi Y. Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain reaction. Br J Ophthalmol. 1997;81(4): 308-313.
12. Eng HL, Lin TM, Chen SY, Wu SM, Chen WJ. Failure to detect human papillomavirus DNA in malignant epithelial neoplasms of conjunctiva by polymerase chain reaction. Am J Clin Pathol. 2002;117(3):429-436.
13. Saegusa M, Takano Y, Hashimura M, Okayasu I, Shiga J. HPV type 16 in conjunctival and junctional papilloma, dysplasia, and squamous cell carcinoma. J Clin Pathol. 1995;48(12):1106-1110.
14. McDonnell PJ, McDonnell JM, Kessis T, Green WR, Shah KV. Detection of human papillomavirus type 6/11 DNA in conjunctival papillomas by in situ hybridization with radioactive probes. Hum Pathol. 1987;18(11):1115-1119.
15. Sjö NC, von Buchwald C, Cassonnet P, et al. Human papillomavirus in normal conjunctival tissue and in conjunctival papilloma: types and frequencies in a large series. Br J Ophthalmol. 2007;91(8):1014-1015.
16. Karcioglu ZA, Issa TM. Human papilloma virus in neoplastic and non-neoplastic conditions of the external eye. Br J Ophthalmol. 1997;81(7):595-598.
17. Sjö N, Heegaard S, Prause JU. Conjunctival papilloma. A histopathologically based retrospective study. Acta Ophthalmol Scand. 2000;78(6): 663-666.
18. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-819.
19. Insinga RP, Dasbach EJ, Myers ER. The health and economic burden of genital warts in a set of private health plans in the United States. Clin Infect Dis. 2003;36(11):1397-1403.
20. Sonnex C, Strauss S, Gray JJ. Detection of human papillomavirus DNA on the fingers of patients with genital warts. Sex Transm Infect. 1999; 75(5):317-319.
21. Egbert JE, Kersten RC. Female genital tract papillomavirus in conjunctival papillomas of infancy. Am J Ophthalmol. 1997;123(4):551-552.
22. Buggage RR, Smith JA, Shen D, Chan CC. Conjunctival papillomas caused by human papillomavirus type 33. Arch Ophthalmol. 2002; 120(2):202-204.
23. Benevides dos Santos PJ, Borborema dos Santos CM, Rufino Mendonça R, Vieira do Carmo MA, Astofi-Filho S. Human papillomavirus type 13infecting the conjunctiva. Diagn Microbiol Infect Dis. 2005;53(1):71-73.
24. Ash JE. Epibulbar tumors. Am J Ophthalmol. 1950;33(8):1203-1219.
25. Shields CL, Shields JA. Tumors of the conjunctiva and cornea. Surv Ophthalmol. 2004;49(1):3-24.
26. de Keizer RJ, de Wolff-Rouendaal D. Topical alpha-interferon in recurrent conjunctival papilloma. Acta Ophthalmol Scand. 2003;81(2):193-196.
27. Yuen HK, Yeung EF, Chan NR, Chi SC, Lam DS. The use of postoperative topical mitomycin C in the treatment of recurrent conjunctival papilloma. Cornea. 2002;21(8):838-839.
28. Shields CL, Lally MR, Singh AD, Shields JA, Nowinski T. Oral cimetidine (Tagamet) for recalcitrant, diffuse conjunctival papillomatosis. Am J Ophthalmol. 1999;128(3):362-364.
29. Howie HL, Katzenellenbogen RA, Galloway DA. Papillomavirus E6 proteins. Virology. 2009;384(2):324-334.
30. McLaughlin-Drubin ME, Münger K. The human papillomavirus E7 oncoprotein. Virology. 2009;384(2):335-344.
31. Halbert CL, Demers GW, Galloway DA. The E6 and E7genes of human papillomavirus type 6 have weak immortalizing activity in human epithelial cells. J Virol. 1992;66(4):2125-2134.
32. Newton R, Ziegler J, Ateenyi-Agaba C, et al. The epidemiology of conjunctival squamous cell carcinoma in Uganda. Br J Cancer. 2002;87(3): 301-308.
33. Ateenyi-Agaba C. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet. 1995;345(8951): 695-696.
34. Scott IU, Karp CL, Nuovo GJ. Human papillomavirus 16 and 18 expression in conjunctival intraepithelial neoplasia. Ophthalmology. 2002;109(3):542-547.
35. McDonnell JM, McDonnell PJ, Sun YY. Human papillomavirus DNA in tissues and ocular surface swabs of patients with conjunctival epithelial neoplasia. Invest Ophthalmol Vis Sci. 1992;33(1):184-189.
36. Tabrizi SN, McCurrach FE, Drewe RH, Borg AJ, Garland SM, Taylor HR. Human papillomavirus in corneal and conjunctival carcinoma. Aust N Z J Ophthalmol. 1997;25(3):211-215.
37. Ateenyi-Agaba C, Franceschi S, Wabwire-Mangen F, et al. Human papillomavirus infection and squamous cell carcinoma of the conjunctiva. Br J Cancer. 2010;102(2):262-267.
38. Tuppurainen K, Raninen A, Kosunen O, et al. Squamous cell carcinoma of the conjunctiva. Failure to demonstrate HPV DNA by in situ hybridization and polymerase chain reaction. Acta Ophthalmol (Copenh). 1992;70(2):248-254.
39. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Human papillomaviruses. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Vol 90. Lyon, France: World Health Organization International Agency for Research on Cancer; 2007.
40. Bonanni P, Boccalini S, Bechini A. Efficacy, duration of immunity and cross protection after HPV vaccination: a review of the evidence. Vaccine. 2009;27 Suppl 1:A46-A53.
41. Kyrgiou M, Shafi M. HPV vaccine. Obstet Gynecol Reprod Med. 2009;19(1):26-28.
42. Muñoz N, Kjaer SK, Sigurdsson K, et al. Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst. 2010;102(5):325-339.